Medline Homecare Beds: FDA Class I Correction for Fire and Entrapment Risks

Medline Industries has issued a critical safety correction involving multiple models of homecare beds following reports of overheating components, electrical hazards, and patient entrapment following reports of overheating components, electrical hazards, and patient entrapment, as detailed in an FDA safety communication.

The U.S. FDA has classified this action as a Class I recall, FDA’s highest risk classification. This indicates that continued use without following updated instructions may result in serious injury or death.

What Is the Issue?

The correction centers on electrical safety risks associated with the bed’s hand control pendant and wiring, which in certain conditions may overheat, melt, spark, cause electrical shock, or catch fire.

These risks are heightened when the bed is operated above its weight limit, movement is obstructed, or motors or components are jammed.

Medline has received reports of burning, smoking, and fire events linked to these issues.

Additional Risk: Patient Entrapment

A secondary but equally serious concern involves patient entrapment, particularly when non-Medline accessories are used. Improper accessories or misuse of the control pendant may result in unintended bed movement, potentially causing entrapment between the bed and rail/accessory, asphyxiation, serious injury, or death.

This risk is especially pronounced in homecare environments, where monitoring may be limited.

Affected Devices

The correction applies to several Medline Basic and Medlite homecare beds, including semi-electric and full-electric models, low-profile variants, and multi-unit packaged configurations (All associated with specific SKUs and UDI-DIs listed in the FDA notice).

Reported Adverse Events

As of December 18, 2025, there were 12 injuries and one death associated with electrical hazards, and two injuries and one death associated with entrapment incidents.

Required Actions for Users

Medline and the FDA recommend the following immediate actions.

Electrical Safety. Keep beds unplugged when not actively adjusting position. Immediately unplug the bed and service if the pendant becomes hot, wiring is damaged, or smoke or sparking occurs.

Safe Operation. For safe operation of the bed, do not exceed weight limits, ensure there are no obstructions to movement, and avoid jammed or stalled components.

Pendant Handling. Do not store the pendant on the mattress. Hang the pendant on the bed frame when not in use.

Accessories. Use only Medline-approved accessories and side rails, and do not use extension cords or third-party components.

Manufacturer Contact Information

Customers with questions or adverse events should contact Medline Industries by phone at 866-359-1704, or by email (recalls@medline.com).

MDP Analysis

This event highlights several critical regulatory and quality system considerations, including electrical safety, risk management, post-market surveillance, human factors and home use risk, and compatibility of accessories that are used with or integrated into the device.

Electrical Safety and IEC 60601 Alignment

The failure mode, overheating and fire risk, points directly to electrical safety and fault condition control, core elements of IEC 60601 compliance.

Risk Management (ISO 14971)

The scenario reflects inadequate control of reasonably foreseeable misuse (e.g., overloading, obstruction) and potential gaps in hazard identification and mitigation.

Post-Market Surveillance

The identification of multiple injuries and deaths demonstrates the importance of complaint trending and the role of real-world data in detecting systemic issues.

Human Factors and Home Use Risk

Homecare environments have reduced supervision and an increased variability in use. Because of this, there is a higher reliance on clear instructions and safe design.

Accessory Compatibility and System Integration

Entrapment risk underscores a recurring issue of a system-level safety breakdown when components are mixed outside intended configurations.

Bottom Line

This correction reinforces a fundamental principle that medical device safety is not just about design; it also depends on real-world use conditions, user behavior, and system integration.

Manufacturers must anticipate not only intended use, but also consider the potential risks of misuse, environmental variability, and third-party interactions with the device.

Links

Read the FDA’s announcement here.

FDA Warns Wild Arabic Herbs Over Product Cancer Claims

FDA Warns Wild Arabic Herbs Over Cancer Claims for Herbal Product FDA issued a warning letter to Wild Arabic Herbs after reviewing the company’s website and determining that its “Edral-17t” product was marketed as an unapproved new drug. FDA cited claims that the...

FDA Warns Amazon for Unapproved Drugs Sold On Its Website

FDA Issues Warning Letter to Amazon for Unapproved Drug Products FDA issued a warning letter to Amazon.com, Inc. after purchasing and reviewing products sold through Amazon’s website and fulfilled through Amazon’s logistics network. The products identified were...

FDA Warns Leading Edge Health Over Unapproved New Drugs

FDA Warning Letter Targets Erectin Stimulating Gel and VigRX Delay Wipes FDA issued a warning letter to Leading Edge Health Inc. after reviewing the company’s website and determining that two sexual health products were being marketed as unapproved new drugs. The...

FDA Targets Online Marketing of Unapproved Drugs

FDA Issues 14 Warning Letters Targeting Online Unapproved Drug Sales The U.S. Food and Drug Administration (FDA) has issued a coordinated series of warning letters targeting companies marketing unapproved drug products online, signaling an intensified enforcement...

FDA Approves First Treatment to Reduce Risk of Acute Pancreatitis

FDA Approves First Treatment Proven to Reduce Acute Pancreatitis Risk in Severe HypertriglyceridemiaAn important example of the distinction between surrogate endpoints and clinical outcomes in drug development The U.S. Food and Drug Administration (FDA) has approved...

Gas Station Drugs: The Regulatory Wild West

Walk into enough gas stations, smoke shops or convenience stores in America and eventually you will encounter a strange modern pharmacy hiding in plain sight. Brightly colored “energy shots.” “Herbal” sexual enhancement pills. Kratom capsules and concentrated...

Medical Device Recalls